Last reviewed · How we verify
NCT03627663
DBT-SS for Cognitively Challenged Individuals With Deliberate Self-harm
NA trial testing Dialectic Behavior Therapy - Skills System in Self Harm in 6 participants. Completed in 1 April 2020.
1 April 2020
Quick facts
| Lead sponsor | Region Skane |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 6 |
| Start date | 10 December 2017 |
| Primary completion | 1 April 2020 |
| Estimated completion | 1 April 2020 |
| Sites | 1 location across Sweden |
Drugs / interventions tested
- Dialectic Behavior Therapy - Skills System
Conditions studied
- Self Harm — all drugs for Self Harm →
- Suicide, Attempted — all drugs for Suicide, Attempted →
- Borderline Personality Disorder — all drugs for Borderline Personality Disorder →
Sponsor
Region Skane — full company profile →
Who can join
Adults 18 to 65, any sex, with Self Harm or Suicide, Attempted. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study evaluates the effect of Dialectic Behavior Therapy Skills System (DBT-SS) in individuals with Intelligence Quotient 65-85 and recurrent self-harm. The study is primarily descriptive with 6 cases followed by repeated measurements (weekly; time series analysis). Primary outcome measure is frequency and severity of self-harming behavior, reported weekly 4 weeks before the start of the intervention, throughout the intervention and 12 weeks after the intervention has stopped.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Dialectical behavior therapy-skills system for cognitively challenged individuals with self-harm: a Swedish pilot study.
Rosendahl-Santillo A, Lantto R, Nylander L, Thylander C, et al · · 2023 · cited 3× · PMID 37346252 · DOI 10.1080/20473869.2021.1965825
Verify or expand the search:
- PubMed search for NCT03627663
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Self Harm
Currently open trials in the same condition.
- NCT06798636 — PsiloIMAGINE: A Psychedelic-augmented Mental Imagery-based Intervention for Young People With Self-harm · EARLY_PHASE1 · recruiting
- NCT06704958 — Augmented Momentary Personal Ecological Risk Evaluation · NA · recruiting
- NCT05602779 — Leverage Noninvasive Transcutaneous Vagus Nerve Stimulation to Reduce Suicidal Behaviors in Vulnerable Adolescents · NA · active not recruiting
- NCT06699732 — Impact of Mindful Self-Compassion Therapy on Self Harm Behaviors, Emotional Regulation and Quality of Life Among Patient · NA · recruiting
- NCT06223867 — Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part A · NA · recruiting
Other Region Skane trials
Trials by the same sponsor.
- NCT07511673 — The Study is a Randomised Clinical Trial (RCT) to Test if Preoperative Dental Screening is Superior to no Preoperative D · NA · not yet recruiting
- NCT07169747 — Safety, Therapeutic Potential, and Mechanisms of Two Psilocybin Doses, Administered With Psychological Support in Young · Phase 2 · recruiting
- NCT07494669 — Proteomics and Physiological Parameters Predicting Complications After Colorectal Cancer Surgery · not yet recruiting
- NCT07462351 — System-integrated Point-of-Care Ultrasound in Breast Cancer Screening · NA · recruiting
- NCT06975696 — Fusion Imaging in Endovascular Thrombectomy for Acute Ischemic Stroke · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03627663 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Region Skane
- Last refreshed: 2 June 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03627663.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing